6533b859fe1ef96bd12b77d2

RESEARCH PRODUCT

The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years

Patrick ManckoundiaValentine NussAlain PutotPhilippe D’athisClémentine RosayJérémie VovelleGilles NuemiAnca-maria MihaiDidier MenuJérémy Barben

subject

Malemedicine.medical_specialtyanticoagulantsVitamin KCross-sectional studyHealth Toxicology and MutagenesisPopulationlcsh:Medicine030204 cardiovascular system & hematologyArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicinePractice Patterns Physicians'Medical prescriptioneducationAgedAged 80 and overeducation.field_of_studyAcenocoumaroldrug prescriptionFluindionebusiness.industrylcsh:RPublic Health Environmental and Occupational HealthWarfarinaged 80 and overoutpatientsCross-Sectional StudiesPrescriptionschemistryAmbulatoryPlatelet aggregation inhibitorFemaleWarfarinbusinessmedicine.drug

description

We compared very elderly people taking vitamin K antagonists (VKA) and those not taking VKA (noVKA). Individuals were included in the noVKA group if there was no VKA on their reimbursed prescriptions during the study period. We also compared three subgroups, constituted by VKA type (fluindione, warfarin, or acenocoumarol). We included individuals aged over 85 years, affiliated to Mutualit&eacute

yearjournalcountryeditionlanguage
2020-09-14International Journal of Environmental Research and Public Health
10.3390/ijerph17186685http://dx.doi.org/10.3390/ijerph17186685